Abstract
A review of the principles and current status of nonradioisotopic immunoassays in the context of therapeutic drug monitoring application is presented. The methods discussed include 1) light scattering, both nephelometric and particle aggregation; 2) fluorescence; 3) immunoenzyme; and 4) chemiluminescence. Basically, all of these methods have demonstrated acceptable sensitivity and replicability for application to drugs of current interest to therapeutic drug monitoring. Each system presents advantages and disadvantages which must be reviewed by the user before making a decision for individual laboratory application.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
